Icotinib Hydrochloride - CAS# 1204313-51-8 Size:Solid 10 mg when added to human plasma

when added to human plasma

Chemical Name: (2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid hydrate

and used to treat a wide variety of infections

which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations

SNI-2011 hydrochloride

Icotinib Hydrochloride - CAS# 1204313-51-8 Size:Solid 10 mg when added to human plasmaIcotinib, also known as BPI 2009, is an orally available quinazoline based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Icotinib selectively inhibits the wild type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, is upregulated in a variety of cancer cell